CITALOPRAM HYDROBRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP26F6376 was issued on June 5, 2026, to DMS Pharmaceutical Group Inc under the overarching delivery order SPE2DX25D9900. The contract was for the procurement of Citalopram Hydrobro, specifically two bottles at a unit price of 3.4400, resulting in a total initial contract value of 6.88 dollars. This order was managed by the DLA Troop Support Medical Supply Chain FSB as part of a larger commercial items framework. Subsequently, modification P00001 was signed on August 26, 2026, which served as a supplemental agreement to cancel the order. This modification cancelled CLIN 0001 and decreased the total contract amount from 6.88 dollars to 0.00 dollars. The cancellation was executed at no cost or liability to either the Government or the contractor, and the contractor accepted the terms, concluding all requirements for this specific order.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
3AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
